Processa Pharmaceuticals(PCSA)
$1.86+0.02 (+1.09%)
PCSA
Processa Pharmaceuticals earnings date
$1.86
At close:+0.02 (+1.09%)
Want to see PCSA full AI Analyst Report?
Processa Pharmaceuticals (PCSA) Q3 2022 Earnings Report
329 Followers
PCSA Q3 2022 EPS Results
- Actual EPS
- -$185.00
- Consensus EPS
- -$168.33
- Beat/Miss
- Missed by -$16.67
- One Year Ago EPS
- -$95.00
PCSA Q3 2022 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/08/2022
- Time
- After Close
- Conference Call
- Tuesday, November 8, 2022
Q3 2022 Earnings Call Audio
PCSA Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
PCSA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 06, 2026 | 2026 (Q2) | ―-1.19 | -6.25 | 81.01% (+5.06) | |
| Nov 05, 2025 | 2025 (Q3) | -2.00-1.81 | -25.75 | 92.98% (+23.94) | |
| Aug 07, 2025 | 2025 (Q2) | -0.22-0.25 | -1.01 | 75.25% (+0.76) | |
| Mar 27, 2025 | 2024 (Q4) | -0.84-0.77 | -1.7 | 54.71% (+0.93) | |
| Oct 30, 2024 | 2024 (Q3) | -25.00-25.75 | -40 | 35.63% (+14.25) | |
| Aug 28, 2024 | 2024 (Q2) | -25.25-25.25 | -50 | 49.50% (+24.75) | |
| Mar 28, 2024 | 2023 (Q4) | -1.60-1.65 | -16.2 | 89.81% (+14.55) | |
| Nov 08, 2023 | 2023 (Q3) | -0.10-0.08 | -0.37 | 78.38% (+0.29) | |
| Aug 10, 2023 | 2023 (Q2) | -0.15-0.10 | -0.32 | 68.75% (+0.22) | |
| May 11, 2023 | 2023 (Q1) | -0.28-0.18 | -0.2 | 10.00% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
